A Critical Review on Health Promoting Benefits of Edible Mushrooms through Gut Microbiota
- PMID: 28885559
- PMCID: PMC5618583
- DOI: 10.3390/ijms18091934
A Critical Review on Health Promoting Benefits of Edible Mushrooms through Gut Microbiota
Abstract
Mushrooms have long been used for medicinal and food purposes for over a thousand years, but a complete elucidation of the health-promoting properties of mushrooms through regulating gut microbiota has not yet been fully exploited. Mushrooms comprise a vast, and yet largely untapped, source of powerful new pharmaceutical substances. Mushrooms have been used in health care for treating simple and common diseases, like skin diseases and pandemic diseases like AIDS. This review is aimed at accumulating the health-promoting benefits of edible mushrooms through gut microbiota. Mushrooms are proven to possess anti-allergic, anti-cholesterol, anti-tumor, and anti-cancer properties. Mushrooms are rich in carbohydrates, like chitin, hemicellulose, β and α-glucans, mannans, xylans, and galactans, which make them the right choice for prebiotics. Mushrooms act as a prebiotics to stimulate the growth of gut microbiota, conferring health benefits to the host. In the present review, we have summarized the beneficial activities of various mushrooms on gut microbiota via the inhibition of exogenous pathogens and, thus, improving the host health.
Keywords: anti-cancer; anti-diabetic; gut microbiota; mushroom; prebiotics.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
A Review on Linking the Medicinal Functions of Mushroom Prebiotics with Gut Microbiota.Int J Med Mushrooms. 2020;22(10):943-951. doi: 10.1615/IntJMedMushrooms.2020035799. Int J Med Mushrooms. 2020. PMID: 33426824 Review.
-
Mushrooms Bioactive as Prebiotics to Modulate Gut Microbiota in Relationships with Causes and Prevention of Liver Diseases (Review).Int J Med Mushrooms. 2020;22(6):509-519. doi: 10.1615/IntJMedMushrooms.2020034706. Int J Med Mushrooms. 2020. PMID: 32865893 Review.
-
Exploring Mushroom Polysaccharides for the Development of Novel Prebiotics: A Review.Int J Med Mushrooms. 2023;25(2):1-10. doi: 10.1615/IntJMedMushrooms.2022046837. Int J Med Mushrooms. 2023. PMID: 36749052 Review.
-
Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review.Int J Biol Macromol. 2022 Apr 15;204:169-192. doi: 10.1016/j.ijbiomac.2022.01.166. Epub 2022 Feb 2. Int J Biol Macromol. 2022. PMID: 35122806 Review.
-
Effects of Rich in Β-Glucans Edible Mushrooms on Aging Gut Microbiota Characteristics: An In Vitro Study.Molecules. 2020 Jun 18;25(12):2806. doi: 10.3390/molecules25122806. Molecules. 2020. PMID: 32570735 Free PMC article. Clinical Trial.
Cited by
-
Intestinal microbial diversity of swines fed with different sources of lithium.3 Biotech. 2024 Apr;14(4):102. doi: 10.1007/s13205-024-03938-3. Epub 2024 Mar 6. 3 Biotech. 2024. PMID: 38464613
-
Chaga mushroom: a super-fungus with countless facets and untapped potential.Front Pharmacol. 2023 Dec 5;14:1273786. doi: 10.3389/fphar.2023.1273786. eCollection 2023. Front Pharmacol. 2023. PMID: 38116085 Free PMC article. Review.
-
Influences of Yogurt with Functional Ingredients from Various Sources That Help Treat Leaky Gut on Intestinal Barrier Dysfunction in Caco-2 Cells.Pharmaceuticals (Basel). 2023 Oct 24;16(11):1511. doi: 10.3390/ph16111511. Pharmaceuticals (Basel). 2023. PMID: 38004377 Free PMC article.
-
Mushroom consumption and hyperuricemia: results from the National Institute for Longevity Sciences-Longitudinal Study of Aging and the National Health and Nutrition Examination Survey (2007-2018).Nutr J. 2023 Nov 22;22(1):62. doi: 10.1186/s12937-023-00887-0. Nutr J. 2023. PMID: 37990262 Free PMC article.
-
Morel (Morchella spp.) intake alters gut microbial community and short-chain fatty acid profiles in mice.Front Nutr. 2023 Sep 22;10:1237237. doi: 10.3389/fnut.2023.1237237. eCollection 2023. Front Nutr. 2023. PMID: 37810928 Free PMC article.
References
-
- Rathee S., Rathee D., Rathee D., Kumar V., Rathee P. Mushrooms as therapeutic agents. Rev. Bras. Farmacogn. 2012;22:457–474. doi: 10.1590/S0102-695X2011005000195. - DOI
-
- Abugri D., McElhenney W.H., Willian K.R. Fatty acid profiling in selected cultivated edible and wild medicinal mushrooms in the Southern United States. J. Exp. Food Chem. 2016;2:1–7. doi: 10.4172/2472-0542.1000108. - DOI
-
- Mhanda F.N., Kadhila-Muandingi N.P., Ueitele I.S.E. Minerals and trace elements in domesticated Namibian Ganoderma species. Afr. J. Biotechnol. 2015;14:3216–3218. doi: 10.5897/AJB2015.14573. - DOI
-
- De Sousa V.M.C., Dos Santos E.F., Sgarbieri V.C. The importance of prebiotics in functional foods and clinical practice. Food Nutr. Sci. 2011;2:4. doi: 10.4236/fns.2011.22019. - DOI
-
- Bhakta M., Kumar P. Mushroom polysaccharides as a potential prebiotics. Int. J. Health Sci. Res. 2013;3:77–84. doi: 10.1016/j.bcdf.2015.11.001. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
